Pavonine Co., Ltd. (KOSDAQ:177830)
3,095.00
+135.00 (4.56%)
At close: Jan 26, 2026
Pavonine Market Cap
Pavonine has a market cap or net worth of 33.94 billion as of January 30, 2026. Its market cap has decreased by -3.94% in one year.
Market Cap
33.94B
Enterprise Value
86.05B
Revenue
134.44B
Ranking
n/a
PE Ratio
14.06
Stock Price
3,095.00
Market Cap Chart
Since August 4, 2014, Pavonine's market cap has decreased from 49.00B to 33.94B, a decrease of -30.73%. That is a compound annual growth rate of -3.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 33.94B | 3.31% |
| Dec 30, 2025 | 32.85B | -6.55% |
| Dec 30, 2024 | 35.16B | -19.11% |
| Dec 28, 2023 | 43.46B | -7.81% |
| Dec 29, 2022 | 47.14B | -24.27% |
| Dec 30, 2021 | 62.25B | -8.36% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| System and Application Technologies | 34.42B |
| Seoul Pharma | 34.39B |
| ITEYES | 34.32B |
| Nexa Dynamics | 34.30B |
| MediaZen | 34.20B |
| NBT Inc. | 34.19B |
| Mohenz.Co.,Ltd. | 33.84B |
| Genolution | 33.78B |